KEGG   DRUG: Ombitasvir - paritaprevir -ritonavir mixtHelp
Entry
D10745            Mixture   Drug                                   

Name
Ombitasvir - paritaprevir -ritonavir mixt;
Technivie (TN)
Product
Component
(Ombitasvir hydrate [DR:D10598] | Ombitasvir [DR:D10576]), (Paritaprevir hydrate [DR:D10597] | Paritaprevir [DR:D10580]), Ritonavir [DR:D00427]
Remark
Therapeutic category: 6250
ATC code: J05AP53
Product: D10745<JP/US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C virus infection [DS:H00413]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP53 Ombitasvir, paritaprevir and ritonavir
      D10745  Ombitasvir - paritaprevir -ritonavir mixt <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D10745  Ombitasvir - paritaprevir -ritonavir mixt
Antiinfectives [br08350.html]
 Antivirals
  D10745
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10745
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10745
BRITE hierarchy
Other DBs
PubChem: 254741706
ChEBI: 90919
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system